{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T08:53:04Z","timestamp":1784364784621,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jnen\/nlab071","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T19:15:58Z","timestamp":1628363758000},"page":"812-820","source":"Crossref","is-referenced-by-count":15,"title":["Pathology Features of Immune and Inflammatory Myopathies, Including a Polymyositis Pattern, Relate Strongly to Serum Autoantibodies"],"prefix":"10.1093","volume":"80","author":[{"given":"Alan","family":"Pestronk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rati","family":"Choksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9]]},"reference":[{"key":"nlab071-B1-20230530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med"},{"key":"nlab071-B2-20230530","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"nlab071-B3-20230530","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0000000000000855","article-title":"Where are we moving in the classification of idiopathic inflammatory myopathies?","volume":"33","author":"Tanboon","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"nlab071-B4-20230530","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"nlab071-B5-20230530","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: Pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"nlab071-B6-20230530","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","article-title":"Integrated diagnosis project for inflammatory myopathies: An association between autoantibodies and muscle pathology","volume":"16","author":"Suzuki","year":"2017","journal-title":"Autoimmun Rev"},{"key":"nlab071-B7-20230530","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","article-title":"Myopathy with anti-Jo-1 antibodies: Pathology in perimysium and neighbouring muscle fibres","volume":"68","author":"Mozaffar","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"nlab071-B8-20230530","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0000000000001422","article-title":"Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy","volume":"84","author":"Stenzel","year":"2015","journal-title":"Neurology"},{"key":"nlab071-B9-20230530","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"key":"nlab071-B10-20230530","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1212\/NXI.0000000000000434","article-title":"Immune myopathies with perimysial pathology: Clinical and laboratory features","volume":"5","author":"Bucelli","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"nlab071-B11-20230530","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.21822","article-title":"Brachio-cervical inflammatory myopathies: Clinical, immune, and myopathologic features","volume":"54","author":"Pestronk","year":"2006","journal-title":"Arthritis Rheum"},{"key":"nlab071-B12-20230530","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mus.21651","article-title":"Vascular pathology in dermatomyositis and anatomic relations to myopathology","volume":"42","author":"Pestronk","year":"2010","journal-title":"Muscle Nerve"},{"key":"nlab071-B13-20230530","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/NEN.0000000000000132","article-title":"Regional ischemic immune myopathy: A paraneoplastic dermatomyopathy","volume":"73","author":"Cai","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"nlab071-B14-20230530","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnen\/nlz111","article-title":"Chronic graft versus host myopathies: Noninflammatory, multi-tissue pathology with glycosylation disorders","volume":"79","author":"Pestronk","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"nlab071-B16-20230530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","article-title":"Inflammatory myopathies with mitochondrial pathology and protein aggregates","volume":"278","author":"Temiz","year":"2009","journal-title":"J Neurol Sci"},{"key":"nlab071-B17-20230530","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","article-title":"Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology","volume":"2","author":"Alshehri","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"nlab071-B18-20230530","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2014-310008","article-title":"Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement","volume":"87","author":"Goyal","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"nlab071-B19-20230530","doi-asserted-by":"crossref","first-page":"100013","DOI":"10.1016\/j.jtauto.2019.100013","article-title":"Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients","volume":"2","author":"Platteel","year":"2019","journal-title":"J Transl Autoimmun"},{"key":"nlab071-B20-20230530","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: Clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"nlab071-B22-20230530","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"key":"nlab071-B23-20230530","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J Autoimmun"},{"key":"nlab071-B24-20230530","doi-asserted-by":"crossref","first-page":"105048","DOI":"10.1016\/j.jbspin.2020.06.021","article-title":"Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study","volume":"88","author":"Leurs","year":"2021","journal-title":"Joint Bone Spine"},{"key":"nlab071-B25-20230530","first-page":"S12","article-title":"Anti-PM-Scl antibody in patients with systemic sclerosis","volume":"30","author":"2nd","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"nlab071-B26-20230530","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"nlab071-B27-20230530","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis","volume":"60","author":"L\u00f3pez De Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"nlab071-B28-20230530","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"nlab071-B29-20230530","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/jcm9123794","article-title":"Pathogenetic mechanisms implicated in Sj\u00f6gren\u2019s syndrome lymphomagenesis: A review of the literature","volume":"9","author":"Stergiou","year":"2020","journal-title":"J Clin Med"},{"key":"nlab071-B30-20230530","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0000000000000641","article-title":"The role of cancer-associated autoantibodies as biomarkers in paraneoplastic myositis syndrome","volume":"31","author":"Lu","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"nlab071-B31-20230530","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/ene.14097","article-title":"Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies","volume":"27","author":"Liu","year":"2020","journal-title":"Eur J Neurol"},{"key":"nlab071-B32-20230530","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","article-title":"Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins","volume":"64","author":"Fujimoto","year":"2012","journal-title":"Arthritis Rheum"},{"key":"nlab071-B33-20230530","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"nlab071-B34-20230530","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: Clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"nlab071-B35-20230530","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/annrheumdis-2017-212436","article-title":"Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis","volume":"77","author":"Yeker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"nlab071-B36-20230530","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/acn3.51294","article-title":"Clinical utility of anti-cytosolic 5'-nucleotidase 1A antibody in idiopathic inflammatory myopathies","volume":"8","author":"Ikenaga","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"nlab071-B37-20230530","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"nlab071-B38-20230530","doi-asserted-by":"crossref","first-page":"e1763","DOI":"10.1212\/WNL.0000000000007260","article-title":"Immune myopathy with large histiocyte-related myofiber necrosis","volume":"92","author":"Pestronk","year":"2019","journal-title":"Neurology"},{"key":"nlab071-B39-20230530","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/acr.23113","article-title":"Association of anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibodies with DRB107:01 and severe myositis in juvenile myositis patients","volume":"69","author":"Kishi","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"nlab071-B40-20230530","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"nlab071-B41-20230530","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"nlab071-B42-20230530","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: Clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"nlab071-B43-20230530","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"key":"nlab071-B44-20230530","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","article-title":"Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis","volume":"78","author":"Sabbagh","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"nlab071-B45-20230530","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-020-01007-3","article-title":"Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups","volume":"8","author":"Nguyen","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"nlab071-B46-20230530","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/rheumatology\/keaa739","article-title":"Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis","volume":"60","author":"Fornaro","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"nlab071-B47-20230530","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum"},{"key":"nlab071-B48-20230530","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1136\/annrheumdis-2017-212915","article-title":"Detection of myositis-specific antibodies","volume":"78","author":"Vulsteke","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"nlab071-B49-20230530","doi-asserted-by":"crossref","first-page":"102465","DOI":"10.1016\/j.autrev.2020.102465","article-title":"Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients","volume":"19","author":"Wesner","year":"2020","journal-title":"Autoimmun Rev"},{"key":"nlab071-B50-20230530","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1212\/WNL.0000000000011269","article-title":"Pathological features of anti-Mi-2 dermatomyositis","volume":"96","author":"Tanboon","year":"2021","journal-title":"Neurology"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnen\/article-pdf\/80\/9\/812\/40449030\/nlab071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.lww.com\/10.1093\/jnen\/nlab071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T20:04:31Z","timestamp":1685477071000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1093\/jnen\/nlab071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,7]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlab071","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,7]]}}}